PTAB Invalidates 3 Procter & Gamble Deodorant Patents

By Editorial Team

The Patent Trial and Appeal Board (PTAB) has ruled to invalidate claims across three more Procter & Gamble (P&G) deodorant patents, marking a significant development in the ongoing legal battle involving personal care product brand Dr. Squatch.

Dr. Squatch has been challenging the validity of P&G's patents, which it was accused of infringing upon in federal court.

The invalidated P&G deodorant patents include:

• 10,905,647 - Antiperspirant and deodorant compositions
• 11,497,706 - Antiperspirant and deodorant compositions
• 10,966,915 - Deodorant compositions

The decision by PTAB to invalidate these patents is a significant win for Dr. Squatch and adds to its successful challenges against P&G's intellectual property.

Law360 subscribers have access to detailed information related to the case, including attached documents such as Final Written Decision '647, Final Written Decision '706, and Final Written Decision '915.

Law firms involved in the case include Jones Day and Venable LLP, representing P&G, while the government agencies overseeing the matter are the Patent Trial and Appeal Board and the U.S. District Court for the Central District of California.

For more in-depth analysis and updates on this case and other legal news, subscribe to Law360 for access to expert analysis, daily newsletters, real-time alerts, and more.